Mizuho cut shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) from a neutral rating to an underperform rating in a report released on Monday, July 10th, Marketbeat.com reports. They currently have $23.00 price target on the real estate investment trust’s stock, down from their previous price target of $25.00.
Several other equities analysts also recently commented on SBRA. Zacks Investment Research downgraded shares of Sabra Healthcare REIT from a buy rating to a hold rating in a research report on Tuesday, April 11th. Cantor Fitzgerald reissued a buy rating and set a $30.00 target price on shares of Sabra Healthcare REIT in a research report on Monday, May 8th. Canaccord Genuity reissued a hold rating and set a $26.00 target price on shares of Sabra Healthcare REIT in a research report on Tuesday, May 9th. Jefferies Group LLC reissued a hold rating and set a $28.00 target price on shares of Sabra Healthcare REIT in a research report on Friday, May 12th. Finally, BidaskClub raised shares of Sabra Healthcare REIT from a sell rating to a hold rating in a research report on Tuesday, June 20th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the stock. Sabra Healthcare REIT currently has an average rating of Hold and an average price target of $26.57.
Shares of Sabra Healthcare REIT (NASDAQ SBRA) traded down 1.79% on Monday, hitting $22.99. The company’s stock had a trading volume of 1,208,514 shares. Sabra Healthcare REIT has a 52 week low of $19.30 and a 52 week high of $29.10. The stock’s 50 day moving average price is $23.62 and its 200 day moving average price is $25.42. The stock has a market capitalization of $1.50 billion, a P/E ratio of 19.35 and a beta of 0.89.
Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, May 8th. The real estate investment trust reported $0.25 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.33. The business had revenue of $62.65 million for the quarter, compared to analyst estimates of $63.47 million. Sabra Healthcare REIT had a return on equity of 8.72% and a net margin of 34.99%. The company’s quarterly revenue was up .1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.54 earnings per share. On average, analysts forecast that Sabra Healthcare REIT will post $1.18 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Sabra Healthcare REIT, Inc. (SBRA) Downgraded by Mizuho to Underperform” was first published by BBNS and is owned by of BBNS. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://baseballnewssource.com/markets/sabra-healthcare-reit-inc-sbra-lowered-to-underperform-at-mizuho-updated-updated-updated/1195303.html.
The company also recently declared a dividend, which will be paid on Friday, August 18th. Shareholders of record on Wednesday, August 16th will be issued a dividend of $0.3599 per share. The ex-dividend date is Monday, August 14th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 145.76%.
A number of large investors have recently added to or reduced their stakes in SBRA. BlackRock Inc. boosted its stake in Sabra Healthcare REIT by 9,246.7% in the first quarter. BlackRock Inc. now owns 9,293,011 shares of the real estate investment trust’s stock worth $259,556,000 after buying an additional 9,193,585 shares during the period. APG Asset Management US Inc. purchased a new stake in Sabra Healthcare REIT during the second quarter worth about $26,582,000. LSV Asset Management boosted its stake in Sabra Healthcare REIT by 45.5% in the first quarter. LSV Asset Management now owns 2,778,914 shares of the real estate investment trust’s stock worth $77,615,000 after buying an additional 868,441 shares during the period. Norges Bank bought a new stake in Sabra Healthcare REIT during the fourth quarter valued at $18,208,000. Finally, Vanguard Group Inc. boosted its stake in Sabra Healthcare REIT by 6.3% in the first quarter. Vanguard Group Inc. now owns 12,432,068 shares of the real estate investment trust’s stock valued at $347,228,000 after buying an additional 734,489 shares during the last quarter. Institutional investors own 99.26% of the company’s stock.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with our FREE daily email newsletter.